BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 1501891)

  • 1. Constitutive expression of exogenous myc in myelomonocytic cells: acquisition of a more transformed phenotype and inhibition of differentiation induction.
    Chisholm O; Stapleton P; Symonds G
    Oncogene; 1992 Sep; 7(9):1827-36. PubMed ID: 1501891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transformation of murine myelomonocytic cells by myc: point mutations in v-myc contribute synergistically to transforming potential.
    Symonds G; Hartshorn A; Kennewell A; O'Mara MA; Bruskin A; Bishop JM
    Oncogene; 1989 Mar; 4(3):285-94. PubMed ID: 2649846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induced p21WAF1 expression acts to reverse myc myelomonocytic cell transformation.
    Dolnikov A; Millington M; Sun LQ; Symonds G
    Cancer Gene Ther; 2000 Nov; 7(11):1491-503. PubMed ID: 11129291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor progression following transformation of murine monocytes by v-myc: acquisition of immortalization and tumorigenicity.
    Stapleton P; Takayama Y; Hartshorn A; Kalaizis A; Rowe PB; Symonds G
    Oncogene; 1991 May; 6(5):807-17. PubMed ID: 1711191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis in v-myc transformation of myelomonocytic cells and its modulation by CSF-1.
    Dolnikov A; Ward RL; Hawkins NJ; Symonds G
    Oncogene; 1996 Mar; 12(6):1189-98. PubMed ID: 8649820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MLL-ENL causes a reversible and myc-dependent block of myelomonocytic cell differentiation.
    Schreiner S; Birke M; García-Cuéllar MP; Zilles O; Greil J; Slany RK
    Cancer Res; 2001 Sep; 61(17):6480-6. PubMed ID: 11522644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The v-myc oncogene.
    Lee CM; Reddy EP
    Oncogene; 1999 May; 18(19):2997-3003. PubMed ID: 10378695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Introduction of v-abl oncogene induces monocytic differentiation of an IL-3-dependent myeloid progenitor cell line.
    Keller JR; Ruscetti SK; Ruscetti FW
    Oncogene; 1990 Apr; 5(4):549-55. PubMed ID: 2158039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic modulation of keratins, vimentin, and alpha-fetoprotein in cultured rat liver epithelial cells after chemical, oncogene, and spontaneous transformation.
    Bisgaard HC; Ton PT; Nagy P; Thorgeirsson SS
    J Cell Physiol; 1994 Jun; 159(3):485-94. PubMed ID: 7514612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential dependence of the tumorigenicity of chemically transformed rat liver epithelial cells on autocrine production of transforming growth factor alpha.
    Duddy SK; Earp HS; Russell WE; Smith GJ; Grisham JW
    Cell Growth Differ; 1995 Mar; 6(3):251-61. PubMed ID: 7794793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The proto-oncogene c-myc in hematopoietic development and leukemogenesis.
    Hoffman B; Amanullah A; Shafarenko M; Liebermann DA
    Oncogene; 2002 May; 21(21):3414-21. PubMed ID: 12032779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phorbol ester-mediated inhibition of growth and regulation of proto-oncogene expression in the human T cell leukemia line JURKAT.
    Makover D; Cuddy M; Yum S; Bradley K; Alpers J; Sukhatme V; Reed JC
    Oncogene; 1991 Mar; 6(3):455-60. PubMed ID: 2011401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between Raf and Myc oncogenes in transformation in vivo and in vitro.
    Cleveland JL; Jansen HW; Bister K; Fredrickson TN; Morse HC; Ihle JN; Rapp UR
    J Cell Biochem; 1986; 30(3):195-218. PubMed ID: 3084503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of acivicin-induced monocytoid differentiation of human myeloid leukemia cells to acivicin-induced modulation of growth factor, cytokine, and protooncogene mRNA expression.
    Weinberg JB; Mason SN
    Cancer Res; 1991 Feb; 51(4):1202-9. PubMed ID: 1997162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autocrine transformation of human hematopoietic cells after transfection with an activated granulocyte/macrophage colony stimulating factor gene.
    Hoyle PE; Steelman LS; McCubrey JA
    Cytokines Cell Mol Ther; 1997 Sep; 3(3):159-68. PubMed ID: 9426974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of c-myc, c-myb, c-fos, c-sis and c-fms proto-oncogene expression and of CSF-1 transcripts and protein by phorbol diester in human malignant histiocytosis DEL cell line with 5q 35 break point.
    Gogusev J; Barbey S; Nezelof C
    Anticancer Res; 1993; 13(4):1043-7. PubMed ID: 8352523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Theophylline induced differentiation provides direct evidence for the deregulation of c-myc in Burkitt's lymphoma and suggests participation of immunoglobulin enhancer sequences.
    Sandlund JT; Neckers LM; Schneller HE; Woodruff LS; Magrath IT
    Cancer Res; 1993 Jan; 53(1):127-32. PubMed ID: 8416737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Both myeloproliferative disease and leukemia are induced by transplantation of bone marrow cells expressing v-myc.
    Bonham L; MacKenzie K; Wood S; Rowe PB; Symonds G
    Oncogene; 1992 Nov; 7(11):2219-29. PubMed ID: 1437146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retroviral v-myc infection of primary fetal liver cells: transformation of monocytes in vitro.
    Birchenall-Roberts MC; Engelmann GL; Keller JR; Lohrey N; Ruscetti FW
    Oncogene; 1989 Jun; 4(6):731-5. PubMed ID: 2786619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the early and late stages of myelomonocytic leukemia induced by Friend helper-independent virus F-MuLV: isolation and induction of Friend myelomonocytic leukemic cell lines.
    Shibuya T; Mak TW
    J Cell Physiol; 1983 Dec; 117(3):283-9. PubMed ID: 6581171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.